Answer:
In this uncontrolled case series of 5 critically ill patients with COVD-19 and acute respiratory distress syndrome (ARDS), administration of convalescent plasma containing neutralizing antibody was followed by an improvement in clinical status.
Meaning These preliminary findings raise the possibility that convalescent plasma transfusion may be helpful in the treatment of critically ill patients with COV19 and ARDS, but this approach requires evaluation in randomized clinical trials.
